Levetiracetam in L-dopa-induced dyskinesia.
Meco
G
G
Fabrizio
E
E
Epifanio
A
A
Di Raimondo
G
G
Vanacore
N
N
Morgante
L
L
D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
D000927:Anticonvulsants; D000978:Antiparkinson Agents; D000077287:Levetiracetam; D007980:Levodopa; D010889:Piracetam